12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several health care stocks experienced significant movements. Vaccinex, Akso Health Group, T2 Biosystems, Vigil Neuroscience, Adagene, and Orgenesis saw their stocks rise, while Novo Integrated Sciences, LumiraDx, Jin Medical International, Cano Health, Universe Pharmaceuticals, and Vivos Therapeutics experienced declines.

October 06, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
LumiraDx stock decreased by 18.52% to $0.14. LumiraDx's stock is trading at a volume of 638.0K shares, which is 434.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.5 million.
The significant decrease in LumiraDx's share price, coupled with a trading volume much higher than its average, indicates a negative investor sentiment and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Novo Integrated Sciences stock declined by 27.0% to $0.34 during Friday's regular session. The current volume of 47.3 million shares is 88.9% of Novo Integrated Sciences's average full-day volume over the last 100 days. The market value of their outstanding shares is at $54.5 million.
The significant decrease in Novo Integrated Sciences' share price, coupled with a trading volume close to its average, indicates a negative investor sentiment and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Akso Health Group stock increased by 26.04% to $1.45, with a trading volume of 425.5K, which is 272.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $33.1 million.
The significant increase in Akso Health Group's share price, coupled with a trading volume higher than its average, indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Vaccinex shares rose 26.8% to $1.04 during Friday's regular session, with a trading volume of 17.8 million, which is 12571.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.0 million.
The significant increase in Vaccinex's share price, coupled with a trading volume much higher than its average, indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100